Literature DB >> 18427760

[Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].

C E Angermann1, S Nitschmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18427760     DOI： 10.1007/s00108-008-2124-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  7 in total

Review 1.  Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.

Authors:  Kumudha Ramasubbu; Jerry Estep; Donna L White; Anita Deswal; Douglas L Mann
Journal:  J Am Coll Cardiol       Date:  2008-01-29       Impact factor: 24.094

2.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

3.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

4.  The relationship between cholesterol and survival in patients with chronic heart failure.

Authors:  Mathias Rauchhaus; Andrew L Clark; Wolfram Doehner; Constantinos Davos; Aidan Bolger; Rakesh Sharma; Andrew J S Coats; Stefan D Anker
Journal:  J Am Coll Cardiol       Date:  2003-12-03       Impact factor: 24.094

5.  Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.

Authors:  John G F Cleland; Alison P Coletta; Ahmed Tageldien Abdellah; Damien Cullington; Andrew L Clark; Alan S Rigby
Journal:  Eur J Heart Fail       Date:  2008-01       Impact factor: 15.534

Review 6.  Risk factor paradox in wasting diseases.

Authors:  Kamyar Kalantar-Zadeh; Tamara B Horwich; Antigone Oreopoulos; Csaba P Kovesdy; Houman Younessi; Stefan D Anker; John E Morley
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-07       Impact factor: 4.294

7.  Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.

Authors:  Luigi Tavazzi; Gianni Tognoni; Maria Grazia Franzosi; Roberto Latini; Aldo Pietro Maggioni; Roberto Marchioli; Gian Luigi Nicolosi; Maurizio Porcu
Journal:  Eur J Heart Fail       Date:  2004-08       Impact factor: 15.534
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.